N-[(het)arylalkyl)] pyrazole(thio)carboxamides and their heterosubstituted analogues
US-8999956-B2 · Apr 7, 2015 · US
US9556121B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9556121-B2 |
| Application number | US-201314441554-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 8, 2013 |
| Priority date | Nov 13, 2012 |
| Publication date | Jan 31, 2017 |
| Grant date | Jan 31, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present application relates to novel pyridyloxyalkylcarboxamides of the formula (I) and to their use as endoparasiticides against endoparasites in animals or humans, and to their use as nematicides for controlling phytopathogenic nematodes, and furthermore to endoparasiticides and nematicides comprising pyridyloxyalkylcarboxamides.
Opening claim text (preview).
The invention claimed is: 1. A method for controlling endoparasites selected from the group consisting of helminths, nematodes, Pentastoma, and Acanthocephala in animals or humans comprising administering prophylactically and/or therapeutically to the animal or human a compound to thereby control said endoparasite, wherein the compound is a compound of formula (I) where Q represents the structural elements below, where n for each Q is in each case as defined below: Y represents hydrogen or represents optionally mono- or poly-M 2 -substituted (C 1 -C 10 )-alkyl, (C 2 -C 10 )-alkenyl, (C 2 -C 10 )-alkynyl, (C 1 -C 10 )-haloalkyl, (C 2 -C 10 )-haloalkenyl, (C 2 -C 10 )-haloalkynyl, (C 1 -C 10 )-alkoxy, (C 2 -C 10 )-alkenyloxy, (C 3 -C 10 )-alkynyloxy, (C 3 -C 14 )-cycloalkyl-(C 1 -C 10 )-alkyl or represents an optionally mono- or poly-M 2 -substituted 3- to 14-membered cyclic group; W represents oxygen or sulphur; L 2 represents —C(R 21 , R 22 )—; L 3 represents —C(R 31 , R 32 )—; M 1 , M 2 and M 3 each independently of one another represent hydrogen, halogen, cyano, nitro, OH, (C 1 -C 10 )-alkyl, (C 1 -C 10 )-haloalkoxy, (C 1 -C 10 )-alkoxy, (C 1 -C 10 )-haloalkoxy, (C 1 -C 10 )-alkylthio, (C 1 -C 10 )haloalkylthio, (C 1 -C 10 )-alkylsulphonyl, (C 1 -C 10 )-haloalkylsulphonyl, (C 1 -C 10 )-alkylsulphanyl, (C 1 -C 10 )-haloalkylsulphanyl or (3- to 14-membered cyclic group)-O—; M 4 represents hydrogen, halogen, cyano, nitro, OH, (C 1 -C 10 )-alkyl, (C 1 -C 10 )-haloalkyl, (C 1 -C 10 )-alkoxy, (C 1 -C 10 )-haloalkoxy, (C 1 -C 10 )-alkylthio, (C 1 -C 10 )-haloalkylthio, (C 1 -C 10 )-alkylsulphonyl, (C 1 -C 10 )-haloalkylsulphonyl, (C 1 -C 10 )-alkylsulphanyl, (C 1 -C 10 )-haloalkylsulphanyl or (3- to 14-membered cyclic group)-O—; k represents 1, 2 or 3; R 21 , R 22 each independently of one another represent hydrogen, halogen or optionally mono- or poly-M 2 -substituted (C 1 -C 10 )-alkyl, (C 2 -C 10 )-alkenyl, (C 2 -C 10 )-alkynyl, (C 1 -C 10 )-haloalkyl, (C 2 -C 10 )-haloalkenyl, (C 2 -C 10 )-haloalkynyl, (C 1 -C 10 )-alkoxy, (C 1 -C 10 )-haloalkoxy, (C 2 -C 10 )-alkenyloxy, (C 3 -C 10 )-alkynyloxy, (C 3 -C 14 )-cycloalkyl-(C 1 -C 10 )-alkyl or represent an optionally mono- or poly-M 2 -substituted 3- to 14-membered cyclic group; or R 21 , R 22 together represent an optionally mono- or poly-M 2 -substituted spiro-attached 3- to 14-membered carbo- or 3- to 10-membered heterocyclic group; R 31 , R 32 each independently of one another represent hydrogen, halogen or optionally mono- or poly-M 2 -substituted (C 1 -C 10 )-alkyl, (C 2 -C 10 )-alkenyl, (C 2 -C 10 )-alkynyl, (C 1 -C 10 )-haloalkyl, (C 2 -C 10 )-haloalkenyl, (C 2 -C 10 )-haloalkynyl, (C 3 -C 14 )-cycloalkyl-(C 1 -C 10 )-alkyl or represent an optionally mono- or poly-M 2 -substituted 3- to 14-membered cyclic group; R 31 , R 32 together represent an optionally mono- or poly-M 5 -substituted spiro-attached 3- to 14-membered carbo- or 3- to 10-membered heterocyclic group; M 5 in each case independently of the others represents halogen, formyl, cyano, nitro, (C 1 -C 10 )-alkyl, (C 1 -C 10 )-haloalkyl, (C 2 -C 10 )-alkenyl, (C 2 -C 10 )-haloalkenyl, (C 2 -C 10 )-alkynyl, (C 2 -C 10 )-haloalkynyl, (C 1 -C 10 )-alkoxy, (C 1 -C 10 )-haloalkoxy, (C 2 -C 10 )-alkenyloxy, (C 2 -C 10 )-haloalkenyloxy, (C 3 -C 10 )-alkynyloxy, (C 3 -C 10 )-haloalkynyloxy, (C 1 -C 10 )-alkylthio, (C 1 -C 10 )-haloalkylthio, (C 2 -C 10 )-alkenylthio, (C 2 -C 10 )-haloalkenylthio, (C 3 -C 10 )-alkynylthio, (C 3 -C 10 )-haloalkynylthio, (C 1 -C 10 )-alkylsulphonyl, (C 1 -C 10 )-haloalkylsulphonyl, (C 2 -C 10 )-alkenylsulphonyl, (C 2 -C 10 )-haloalkenylsulphonyl, (C 3 -C 10 )-alkynylsulphonyl, (C 3 -C 10 )-haloalkynylsulphonyl, (C 1 -C 10 )-alkylsulphanyl, (C 1 -C 10 )-haloalkylsulphanyl, (C 2 -C 10 )-alkenylsulphanyl, (C 2 -C 10 )-haloalkenylsulphanyl, (C 3 -C 10 )-alkynylsulphanyl, (C 3 -C 10 )-haloalkynylsulphanyl, (C 1 -C 10 )-alkylcarbonyl, (C 1 -C 10 )-haloalkylcarbonyl, (C 2 -C 10 )-alkenylcarbonyl, (C 2 -C 10 )-haloalkenylcarbonyl, (C 2 -C 10 )-alkynylcarbonyl, (C 2 -C 10 )-haloalkynylcarbonyl, (C 1 -C 10 )-alkoxycarbonyl, (C 1 -C 10 )-haloalkoxycarbonyl, (C 2 -C 10 )-alkenyloxycarbonyl, (C 2 -C 10 )-haloalkenyloxycarbonyl, (C 3 -C 10 )-alkynyloxycarbonyl, (C 3 -C 10 )-haloalkynyloxycarbonyl, (C 1 -C 10 )-alkylcarbonyloxy, (C 1 -C 10 )-haloalkylcarbonyloxy, (C 2 -C 10 )-alkenylcarbonyloxy, (C 2 -C 10 )-haloalkenylcarbonyloxy, (C 2 -C 10 )-alkynylcarbonyloxy, (C 2 -C 10 )-haloalkynylcarbonyloxy, a 3- to 14-membered cyclic group; and/or a salt, N-oxide and/or tautomeric form of a compound of the formula (I), except for the compounds N-[2-(pyridin-2-yloxy)ethyl]-4-(trifluoromethyl)nicotinamide: and 4-(trifluoromethyl)-N-(2-{[5-(trifluoromethyl)pyridin-2-yl]oxy}ethyl)nicotinamide: 2. A method according to claim 1 where Q represents the structural elements below, where n for each Q is in each case as defined below: Y represents hydrogen or represents optionally mono- or poly-M 2 -substituted (C 1 -C 6 )-alkyl, (C 2 -C 6 )-alkenyl, (C 2 -C 6 )-alkynyl, (C 1 -C 6 )-haloalkyl, (C 2 -C 6 )-haloalkenyl, (C 2 -C 6 )-haloalkynyl, (C 1 -C 6 )-alkoxy, (C 2 -C 6 )-alkenyloxy, (C 3 -C 6 )-alkynyloxy, (C 3 -C 10 )-cycloalkyl-(C 1 -C 6 )-alkyl or represents an optionally mono- or poly-M 2 -substituted 3- to 10-membered cyclic group; W represents oxygen, M 1 , M 2 and M 3 each independently of one another represent hydrogen, halogen, cyano, nitro, OH, (C 1 -C 6 )-alkyl, (C 1 -C 6 )-haloalkyl, (C 1 -C 6 )-alkoxy, (C 1 -C 6 )-haloalkoxy, (C 1 -C 6 )-alkylthio, (C 1 -C 6 )-haloalkylthio, (C 1 -C 6 )-alkylsulphonyl, (C 1 -C 6 )-haloalkylsulphonyl, (C 1 -C 6 )-alkylsulphanyl, (C 1 -C 6 )-haloalkylsulphanyl, (C 3 -C 14 )-cycloalkyl-O—, (C 3 -C 14 )-cycloalkenyl-O—, (C 6 -C 14 )-aryl-O—, halogenated (C 3 -C 14 )-cycloalkyl-O—, halogenated (C 3 -C 14 )-cycloalkenyl-O—, halogenated (C 6 -C 14 )-aryl-O—, where, if Q corresponds to Q 11 , M 3 is not (C 1 -C 4 )-haloalkyl in position 4 at the pyridyl; M 4 represents hydrogen, halogen, cyano, nitro, OH, (C 1 -C 6 )-alkyl, (C 1 -C 6 )-haloalkyl, (C 1 -C 6 )-alkoxy, (C 1 -C 6 )-haloalkoxy, (C 1 -C 6 )-alkylthio, (C 1 -C 6 )-haloalkylthio, (C 1 -C 6 )-alkyl sulphonyl, (C 1 -C 6 )-haloalkylsulphonyl, (C 1 -C 6 )-alkylsulphanyl, (C 1 -C 6 )-haloalkylsulphanyl, (C 3 -C 14 )-cycloalkyl-O—, (C 3 -C 14 )-cycloalkenyl-O—, (C 6 -C 14 )-aryl-O—, halogenated (C 3 -C 14 )-cycloalkyl-O—, halogenated (C 3 -C 14 )-cycloalkenyl-O—, halogenated (C 6 -C 14 )-aryl-O—, where, if Q corresponds to Q 10 , M 4 is not (C 1 -C 4 )-haloalkyl; k represents for 2; R 21 , R 22 each independently of one another represent hydrogen, fluorine or optionally mono- or poly-M 2 -substituted (C 1 -C 6 )-alkyl, (C 2 -C 6 )-alkenyl, (C 2 -C 6 )-alkynyl, (C 1 -C 6 )-haloalkyl, (C 2 -C 6 )-haloalkenyl, (C 2 -C 6 )-haloalkynyl, (C 1 -C 6 )-alkoxy, (C 1 -C 6 )-haloalkoxy, (C 2 -C 6 )-alkenyloxy, (C 3 -C 6 )-alkynyloxy, (C 3 -C 6 )-cycloalkyl-(C 1 -C 6 )-alkyl or represent an optionally mono- or poly-M 2 -substituted (C 3 -C 14 )-carbocyclic group; or
linked by a chain containing hetero atoms as chain links · CPC title
Nitriles · CPC title
linked by a chain containing hetero atoms as chain links · CPC title
Antiparasitic agents · CPC title
1,2-Diazoles; Hydrogenated 1,2-diazoles · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.